4.1 Article

Medical Treatment of Female Sexual Dysfunction

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

The role of hormone therapy in urogenital health after menopause

Rossella E. Nappi et al.

Summary: Menopause presents challenges to urogenital health due to hormonal changes, leading to tissue degeneration. Genitourinary syndrome of menopause (GSM) is a clinical condition involving vaginal atrophy that negatively impacts quality of life.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Obstetrics & Gynecology

The Role of Progestogens in Menopausal Hormone Therapy

James H. Liu

Summary: This article discusses the role of progestogens in menopausal hormone therapy, the properties of several commonly used progestogens, and their impact on various target tissues. It also presents current clinical regimens for clinicians to utilize in practice.

CLINICAL OBSTETRICS AND GYNECOLOGY (2021)

Review Geriatrics & Gerontology

Genitourinary Syndrome of Menopause: Current Treatment Options in Breast Cancer Survivors - Systematic Review

Eduard Mension et al.

Summary: Breast cancer survivors often experience atrophic vaginitis due to persistent estrogen suppression treatments, but the use of local estrogen therapy is limited in these women due to treatment controversies. Non-hormonal treatments are the first-line therapy for vulvovaginal atrophy in this population, with concerns remaining about safety of alternative options like local estrogen, laser therapy, and local androgens.

MATURITAS (2021)

Article Multidisciplinary Sciences

A survival of the fittest strategy for the selection of genotypes by which drug responders and non-responders can be predicted in small groups

Daniel Hohle et al.

Summary: Phenotype Prediction Scores (PPS) can effectively predict the efficacy of drug treatments in small samples by filtering SNPs to obtain stable risk alleles for predicting the treatment outcomes of FSIAD patients.

PLOS ONE (2021)

Review Urology & Nephrology

The Evolution of the Female Sexual Disorder/Dysfunction Definitions, Nomenclature, and Classifications: A Review of DSM, ICSM, ISSWSH, and ICD

Sharon J. Parish et al.

Summary: The ICSM and ISSWSH contrasted with the DSM classification regarding FSD, providing evidence-based guidelines on definitions, nomenclature, and diagnostic criteria, emphasizing the separation of female sexual desire and arousal disorders, elaborating on subtypes of arousal problems, broadening the scope of sexual pain definitions, and deepening the understanding of etiologies and risk factors for FSD.

SEXUAL MEDICINE REVIEWS (2021)

Review Pharmacology & Pharmacy

Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder

Danielle Mayer et al.

ANNALS OF PHARMACOTHERAPY (2020)

Article Pharmacology & Pharmacy

Evaluation of safety for flibanserin

Anita H. Clayton et al.

EXPERT OPINION ON DRUG SAFETY (2020)

Article Pharmacology & Pharmacy

An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause

Michele Holton et al.

EXPERT OPINION ON PHARMACOTHERAPY (2020)

Article Public, Environmental & Occupational Health

Female Hypoactive Sexual Desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment

Sheryl A. Kingsberg et al.

JOURNAL OF WOMENS HEALTH (2020)

Review Obstetrics & Gynecology

Premature ovarian insufficiency: an International Menopause Society White Paper

N. Panay et al.

CLIMACTERIC (2020)

Review Urology & Nephrology

Trazodone in Sexual Medicine: Underused and Overdosed?

Robert E. Pyke

SEXUAL MEDICINE REVIEWS (2020)

Article Obstetrics & Gynecology

The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society

[Anonymous]

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)

Editorial Material Pharmacology & Pharmacy

What are the challenges in prescribing pharmacotherapy for female sexual dysfunctions?

Rossella E. Nappi et al.

EXPERT OPINION ON PHARMACOTHERAPY (2019)

Review Endocrinology & Metabolism

Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data

Rakibul M. Islam et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

Review Obstetrics & Gynecology

Vulvovaginal atrophy in women after cancer

P. Cox et al.

CLIMACTERIC (2019)

Article Obstetrics & Gynecology

Global Consensus Position Statement on the Use of Testosterone Therapy for Women

Susan R. Davis et al.

CLIMACTERIC (2019)

Article Pharmacology & Pharmacy

Bremelanotide: First Approval

Sohita Dhillon et al.

DRUGS (2019)

Review Endocrinology & Metabolism

Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women

Rossella E. Nappi et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Article Obstetrics & Gynecology

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder Two Randomized Phase 3 Trials

Sheryl A. Kingsberg et al.

OBSTETRICS AND GYNECOLOGY (2019)

Article Obstetrics & Gynecology

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

James A. Simon et al.

OBSTETRICS AND GYNECOLOGY (2019)

Article Endocrinology & Metabolism

Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause

David F. Archer et al.

EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2019)

Review Obstetrics & Gynecology

Sexual well-being after menopause: An International Menopause Society White Paper

J. A. Simon et al.

CLIMACTERIC (2018)

Article Pharmacology & Pharmacy

Expert opinion on existing and developing drugs to treat female sexual dysfunction

Melanie K. Miller et al.

EXPERT OPINION ON EMERGING DRUGS (2018)

Article Endocrinology & Metabolism

Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors

Susan R. Davis et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Review Urology & Nephrology

Couplepause: A New Paradigm in Treating Sexual Dysfunction During Menopause and Andropause

Emmanuele A. Jannini et al.

SEXUAL MEDICINE REVIEWS (2018)

Article Obstetrics & Gynecology

Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause

Fernand Labrie et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)

Review Urology & Nephrology

Flibanserin: From Bench to Bedside

Erin M. Dooley et al.

SEXUAL MEDICINE REVIEWS (2017)

Article Obstetrics & Gynecology

2016 IMS Recommendations on women's midlife health and menopause hormone therapy

R. J. Baber et al.

CLIMACTERIC (2016)

Review Geriatrics & Gerontology

Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)

Rossella E. Nappi et al.

MATURITAS (2016)

Editorial Material Medicine, General & Internal

FDA Approval of Flibanserin - Treating Hypoactive Sexual Desire Disorder

Hylton V. Joffe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Pharmacology & Pharmacy

Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women

Ida Dhanuka et al.

EXPERT OPINION ON PHARMACOTHERAPY (2015)

Review Pharmacology & Pharmacy

Advances in pharmacotherapy for treating female sexual dysfunction

Rossella E. Nappi et al.

EXPERT OPINION ON PHARMACOTHERAPY (2015)

Review Geriatrics & Gerontology

Update on management of genitourinary syndrome of menopause: A practical guide

Santiago Palacios et al.

MATURITAS (2015)

Review Endocrinology & Metabolism

Testosterone in women-the clinical significance

Susan R. Davis et al.

LANCET DIABETES & ENDOCRINOLOGY (2015)

Review Pharmacology & Pharmacy

Drugs in early clinical development for the treatment of female sexual dysfunction

Zoe R. Belkin et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)

Review Pharmacology & Pharmacy

Sexual dysfunction associated with major depressive disorder and antidepressant treatment

Anita H. Clayton et al.

EXPERT OPINION ON DRUG SAFETY (2014)

Article Obstetrics & Gynecology

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial

James A. Simon et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2014)

Article Obstetrics & Gynecology

Pharmacogenomics and sexuality: a vision

R. E. Nappi et al.

CLIMACTERIC (2013)

Article Endocrinology & Metabolism

DHEA Replacement for Postmenopausal Women

Susan R. Davis et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Review Obstetrics & Gynecology

Therapeutic options for postmenopausal female sexual dysfunction

F. Al-Azzawi et al.

CLIMACTERIC (2010)

Article Obstetrics & Gynecology

Recommendations for the management of postmenopausal vaginal atrophy

D. W. Sturdee et al.

CLIMACTERIC (2010)

Review Endocrinology & Metabolism

Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials

Nicoletta Biglia et al.

GYNECOLOGICAL ENDOCRINOLOGY (2010)

Review Medicine, General & Internal

Vulvovaginal Atrophy

Maire B. Mac Bride et al.

MAYO CLINIC PROCEEDINGS (2010)

Review Urology & Nephrology

Sildenafil citrate for female sexual arousal disorder: a future possibility?

Corina Schoen et al.

NATURE REVIEWS UROLOGY (2009)

Article Geriatrics & Gerontology

The effects of oestrogen on urogenital health

Michele Lachowsky et al.

MATURITAS (2009)

Article Geriatrics & Gerontology

The challenge of talking about sex: The importance of patient-physician interaction

Ulrike Brandenburg et al.

MATURITAS (2009)

Article Obstetrics & Gynecology

Sexual Problems and Distress in United States Women Prevalence and Correlates

Jan L. Shiften et al.

OBSTETRICS AND GYNECOLOGY (2008)